212 filings
8-K
HBIO
Harvard Bioscience Inc.
3 Apr 24
Entry into a Material Definitive Agreement
8:01am
8-K
HBIO
Harvard Bioscience Inc.
26 Mar 24
Departure of Directors or Certain Officers
5:00pm
8-K
HBIO
Harvard Bioscience Inc.
7 Mar 24
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
7:00am
8-K
HBIO
Harvard Bioscience Inc.
5 Jan 24
Results of Operations and Financial Condition
5:01pm
8-K
HBIO
Harvard Bioscience Inc.
7 Nov 23
Harvard Bioscience Announces Third Quarter 2023 Financial Results
7:00am
8-K
41ql9f8
8 Aug 23
Harvard Bioscience Announces Second Quarter 2023 Financial Results
9:05am
8-K
5hilz7zzr h8
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am
8-K
urwiyqwp00ejr0nb1
15 May 23
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
wd6m9u
25 Apr 23
Harvard Bioscience Announces First Quarter 2023 Financial Results
8:00am
8-K
11wbe mh9oyp
13 Mar 23
Other Events
5:28pm
8-K
53rcmr q3
10 Mar 23
Departure of Directors or Certain Officers
8:00am
8-K
2fmpso8tit f6h4nu
9 Mar 23
Harvard Bioscience Announces Fourth Quarter 2022 Financial Results
7:00am
8-K
hroa0hn
19 Jan 23
Departure of Directors or Certain Officers
5:00pm
8-K/A
gt0opj
3 Jan 23
Departure of Directors or Certain Officers
8:45am
8-K
017b4fnbtheqphm6ald
12 Dec 22
Harvard Bioscience Announces CFO Transition
8:31am
8-K
1m6d2t1qqus pvy9uz
8 Nov 22
Harvard Bioscience Announces Third Quarter 2022 Financial Results
4:02pm
8-K
94y1mxlz 2v09pb3m
4 Aug 22
Harvard Bioscience Announces Second Quarter 2022 Financial Results
7:01am
8-K
ksj6sajy
17 May 22
Departure of Directors or Certain Officers
4:39pm
8-K
md7 uxi915lnxsid6fui
4 May 22
Harvard Bioscience Announces First Quarter 2022 Financial Results
7:01am
8-K
ssas6mz44xem
28 Apr 22
Entry into a Material Definitive Agreement
12:00am